Results 51 to 60 of about 30,447 (273)
Prevention of vaginal atrophy after treatment for tumors of the female reproductive system
This article discusses the problems of rational pharmacotherapy in women with vulvovaginal atrophy developed after gynecological operations or during combination treatment for tumors of the female reproductive system.
A. G. Kedrova
doaj +1 more source
Interrelationships among endometriosis-related pain symptoms and their effects on health-related quality of life: a sectional observational study [PDF]
ObjectiveTo assess the correlation between different pain symptoms and different domains of women's health-related quality of life (HRQoL).MethodsSeventy-seven women with deep infiltrating endometriosis were successively enrolled between June 2011 and ...
Marlon de Freitas Fonseca +4 more
doaj +1 more source
Endometriosis-associated pain is an essential factor in deciding surgical indications of endometriosis. However, there is no quantitative method to diagnose the intensity of local pain in endometriosis (especially deep endometriosis).
Masao Ichikawa +9 more
doaj +1 more source
Contested psychiatric ontology and feminist critique : 'female sexual dysfunction' and the diagnostic and statistical manual [PDF]
In this article I discuss the emergence of Female Sexual Dysfunction (FSD) within American psychiatry and beyond in the postwar period, setting out what I believe to be important and suggestive questions neglected in existing scholarship.
Angel, Katherine
core +1 more source
Long‐term results of the Musset surgical technique in the treatment of recto‐vaginal fistulas
Abstract Objective Recto‐vaginal fistulas (RVF) are a rare pathology, mostly affecting developing countries. They are mainly obstetrical (88% of cases) and have an incidence of 0.5%. Musset's surgical technique in the management of RVF has been the subject of few studies and there is little data in the literature concerning the evaluation of its long ...
Joy Bloomfield +5 more
wiley +1 more source
Ospemifene May Not Treat Vulvar Atrophy: A Report of Two Cases
Introduction: Ospemifene (Osphena, Shionogi Inc, Florham, NJ, USA) is an estrogen agonist and antagonist approved by the U.S. Federal Drug Administration for the treatment of “moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due ...
Andrew T. Goldstein, MD +1 more
doaj +1 more source
Painful coitus often prevents sexual satisfaction. The symptom of dyspareunia presents special propblems for the patient and for the doctor. A family physician with sexual knowledge, self-awareness, and time to carefully counsel and examine the patient can adequately manage many patients with this complaint.Dealing with painful intercourse can be ...
openaire +3 more sources
Abstract Objective To compare the efficacy and safety of fractional microablative radiofrequency (RF) and topical estriol in the treatment of genitourinary syndrome of menopause (GSM). Methods This pilot randomized controlled trial included 30 healthy postmenopausal women with GSM.
Priscila de Almeida Torre +6 more
wiley +1 more source
Background Evidence points toward shared characteristics between female survivors of sexual abuse and women with dyspareunia. This study explored, for the first time, similarities and differences between women who were exposed to sexual abuse to those ...
Michal Granot +6 more
doaj +1 more source
Female sexual dysfunction: Indian perspective and role of Indian gynecologists
Background: One rarely finds Indian women talking about their sexuality like this due to sex taboo in our society. This does not mean that sexual dysfunction is uncommon in Indian women. Female sexual dysfunction is widely prevalent.
Nilanchali Singh +2 more
doaj +1 more source

